ProCE Banner Activity

SOLAR 3D: Wk 48 Results of Switching to DTG/3TC From Suppressive 3- or 4-Drug ART in PWH With M184V/I Mutations and Virologic Failure

Slideset Download
Conference Coverage
In open-label study, 2-drug regimen was found to be safe and effective at maintaining virologic suppression in patients with multiple previous virologic failures and historic or current M184V/I.

Released: November 02, 2021

Expiration: November 01, 2022

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp

ViiV Healthcare